The batch was distributed between August 14, 2018 and September 5, 2018. One nonfatal adverse event has been reported during the timeframe the affected product was distributed. Ferring has announced a ...

ROCKVILLE, Md., Dec.4, 2007-- FDA notified healthcare professionals and patients of the Agency's request that manufacturers update the prescribing information for desmopressin to include important new ...

Nasal sprays are often used as decongestants A pharma recalled several nasal sprays due to excessive presence of man-made hormone desmopressin Risk factors include seizure, coma and even death Ferring ...

Dr. Reddy’s is launching desmopressin acetate injection, in a dosage strength of 4 mcg/mL. The product is the generic of Ferring’s DDAVP (desmopressin acetate) injection. “The launch of Desmopressin ...

Ferring Inc. is recalling three lots of DDAVP Spray (desmopressin acetate nasal solution, 10 micrograms/spray) because the product may contain a higher than labelled dose of the active ingredient ...

Is Desmopressin acetate (DDAVP) for bed wetting the same as the The vasopressin analog desmopressin (DDAVP) known to enhance memory. Answer::Dear einstein, The Desmopressin is probably the same but as ...

Desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus, and for the management of primary nocturnal enuresis. Aurobindo has ...

Feb. 18, 2005 — The U.S. Food and Drug Administration (FDA) has approved a first-time generic formulation of terconazole vaginal cream 0.4% for the treatment of vulvovaginal candidiasis; a first-time ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced Wednesday the launch of Desmopressin Acetate Injection USP, 4 mcg/mL Single-dose Ampules in the U.S. market. Desmopressin Acetate Injection is ...

Isreali drugmaker Teva Pharmaceutical Industries has received the regulatory nod in the USA for its Abbreviated New Drug Application for Desmopressin Acetate Tablets, 0.1mg and 0.2mg. Isreali ...